LOS ANGELES - M. Roy Wilson, M.D., M.S., the former chairman of the Board of Trustees at Charles R. Drew University of Medicine and Science, was appointed to an executive role with the National Institute on Minority Health and Health Disparities, the organization announced today.
Dr. Wilson will help direct strategic planning and coordinate programs for the agency, which is part of the National Institutes of Health. Moreover, Dr. Wilson, in tandem with NIH Institutes and Centers, will oversee plans for integrating the NIH minority health and health disparities research portfolio.
“Dr. Wilson is a well-respected physician and academician who brings extensive senior-level administrative experience that will be vital to NIMHD,” John Ruffin, Ph.D., who heads the Institute on Minority Health and Health Disparities said in a prepared statement.
“I am very excited to have Dr. Wilson join us at a time when the NIMHD is transitioning to an institute. His exceptional leadership will be especially crucial as the NIMHD seeks to strengthen its coordination role of all minority health and health disparities research at NIH.”
Dr. Wilson, a renowned ophthalmologist, researcher and academic executive, was appointed in 1996 as dean, College of Medicine, at Charles R. Drew University of Medicine and Science. He later became dean at the Creighton University School of Medicine; president of the Texas Tech University Health Sciences Center, Amarillo; and chancellor of the University of Colorado, Denver.
In September 2010, Dr. Wilson returned to Charles R. Drew University of Medicine and Science as acting president and board of trustees’ chairman. Through his stewardship, the University received full accreditation earlier this year by the Western Association of Schools and Colleges, and bolstered its finances. During his tenure, the University last year also named a new president, David M. Carlisle, M.D. Ph.D, and appointed a new board chairman, James Lott.
Dr. Wilson is a long-time elected member of the Institutes of Medicine of the National Academy of Sciences, the American Ophthalmological Society and the Glaucoma Research Society. Over his career, he was named to the list of Best Doctors in America 14 times. He also was selected last year as a finalist for the Los Angeles Business Journal’s Healthcare CEO of the Year.
Dr. Wilson received over the years numerous honors, including the Distinguished Physician Award from the Minority Health Institute, the Herbert W. Nickens Award from the Association of American Medical Colleges and the Senior Achievement Award from the American Academy of Ophthalmology.
He also was named recently to the advisory councils of the National Institute on Minority Health and Health Disparities and the former National Center for Research Resources, along with the NIH Director’s Working Group on Diversity in the Biomedical Research Workplace.
Dr. Wilson completed his undergraduate studies at Allegheny College, his masters in epidemiology from the University of California, Los Angeles and his M.D. from Harvard Medical School. He has delivered more than 200 lectures and published more than 300 articles, abstracts and book chapters.
About the National Institute on Minority Health and Health Disparities: The institute, which is part of the NIH, leads scientific research to improve minority health. It also seeks to eliminate health disparities by conducting and supporting research on minority health and health disparities; planning, reviewing, coordinating, and evaluating all minority health and health disparities research at NIH; promoting and supporting the training of a diverse research workforce; translating and disseminating research information; and fostering collaborations and partnerships. For more information about NIMHD, visit http://www.nimhd.nih.gov/.
About the National Institutes of Health: NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.